loadpatents
name:-0.14397406578064
name:-0.010096073150635
name:-0.00046610832214355
McSwiggen; James A. Patent Filings

McSwiggen; James A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McSwiggen; James A..The latest application filed is for "ccr5 and cd4 sirna-targeted phospholipid nanosomes therapeutics for treatment of hiv-1 and other diseases".

Company Profile
0.8.23
  • McSwiggen; James A. - Boulder CO
  • McSwiggen; James A. - Solon OH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
CCR5 and CD4 siRNA-Targeted Phospholipid Nanosomes Therapeutics for Treatment of HIV-1 and Other Diseases
App 20220144629 - Castor; Trevor Percival ;   et al.
2022-05-12
RNA Interference Mediated Inhibition of Protein Tyrosine Phosphatase-1B (PTP-1B) Gene Expression Using Short Interfering RNA
App 20090233983 - McSwiggen; James A.
2009-09-17
siRNA treatment of diseases or conditions related to levels of IKK-gamma
Grant 7,022,828 - McSwiggen April 4, 2
2006-04-04
RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA
App 20050261212 - McSwiggen, James A.
2005-11-24
Method and reagent for inhibiting hepatitis B viral replication
App 20040054156 - Draper, Kenneth ;   et al.
2004-03-18
RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA
App 20040019001 - McSwiggen, James A.
2004-01-29
RNA interference mediated inhibition of hepatitis B virus (HBV) using short interfering nucleic acid (siNA)
App 20030206887 - Morrissey, David ;   et al.
2003-11-06
RNA interference mediated treatment of Alzheimer's disease using short interfering RNA
App 20030190635 - McSwiggen, James A.
2003-10-09
Method and reagent for the treatment of asthma and allergic conditions
App 20030191077 - Fosnaugh, Kathy ;   et al.
2003-10-09
Enzymatic nucleic acid treatment of diseases of conditions related to levels of epidermal growth factor receptors
Grant 6,623,962 - Akhtar , et al. September 23, 2
2003-09-23
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
App 20030175950 - McSwiggen, James A.
2003-09-18
RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)
App 20030170891 - McSwiggen, James A.
2003-09-11
RNA interference mediated inhibition of prostaglandin D2 receptor (PTGDR) and prostaglandin D2 synthetase (PTGDS) gene expression using short interfering RNA
App 20030148507 - Fosnaugh, Kathy ;   et al.
2003-08-07
RNA interference mediated inhibition of adenosine A1 receptor (ADORA1) gene expression using short interfering RNA
App 20030143732 - Fosnaugh, Kathy ;   et al.
2003-07-31
Method and reagent for the treatment of alzheimer's disease
App 20030143708 - Blatt, La Wrence ;   et al.
2003-07-31
Enzymatic nucleic acid treatment of diseases or conditions related to levels of IKK-gamma and PKR
App 20030119017 - McSwiggen, James A.
2003-06-26
Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
Grant 6,566,127 - Pavco , et al. May 20, 2
2003-05-20
Method and reagent for inhibiting hepatitis B virus replication
App 20030068301 - Draper, Kenneth ;   et al.
2003-04-10
Nucleic acid sensor molecules
App 20030065155 - Usman, Nassim ;   et al.
2003-04-03
Method and reagent for the treatment of cardiac disease
App 20030050259 - Blatt, Lawrence ;   et al.
2003-03-13
Compositions and method for modulation of gene expression in plants
App 20030014775 - Zwick, Michael G. ;   et al.
2003-01-16
Nucleic acid sensor molecules
App 20030008295 - Usman, Nassim ;   et al.
2003-01-09
Nucleic acid sensor molecules
App 20020102568 - Usman, Nassim ;   et al.
2002-08-01
Enzymatic Nucleic Acid Treatment Of Diseases Or Conditions Related To Hepatitis C Virus Infection
App 20020082225 - BLATT, LAWRENCE ;   et al.
2002-06-27
Nucleic acid encoding delta-9 desaturase
Grant 6,350,934 - Zwick , et al. February 26, 2
2002-02-26
Enzymatic nucleic acid treatment of disases or conditions related to hepatitis c virus infection
App 20020013458 - Blatt, Lawrence ;   et al.
2002-01-31
Enzymatic nucleic acids that cleave C-fos
Grant 6,103,890 - Jarvis , et al. August 15, 2
2000-08-15
Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
Grant 6,057,156 - Akhtar , et al. May 2, 2
2000-05-02
Hairpin ribozymes
Grant 6,022,962 - Chowrira , et al. February 8, 2
2000-02-08
Assay for Ribozyme target site
Grant 5,525,468 - McSwiggen June 11, 1
1996-06-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed